Clinical

Dataset Information

0

A Self-controlled Trial of Prophylactic Topical Application of Vitamin K1 Cream for Cetuximab-related Skin Rash -VANQUISH trial-


ABSTRACT: Interventions: Vitamin K1 cream Plcebo cream Primary outcome(s): The incidence of grade2-5 rash acneiform (CTCAE v4.0) of face whithin 4 weeks from starting cetuximab containing chemotherapy Study Design: Parallel Randomized

DISEASE(S): Colorectal Cancer

PROVIDER: 2625669 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

2024-08-20 | GSE272008 | GEO
| 2108857 | ecrin-mdr-crc
| 2146434 | ecrin-mdr-crc
| PRJNA905668 | ENA
2024-09-12 | PXD043034 | Pride
| S-EPMC10034663 | biostudies-literature
| PRJNA1092872 | ENA
| 2106044 | ecrin-mdr-crc
| PRJNA1134616 | ENA
| 2150735 | ecrin-mdr-crc